new "designer estrogen," Evista

Lilly is now promoting their new "designer estrogen," Evista.

It'll be used as an alternative to prevent osteoporosis in postmenopausal women.

Evista (raloxifene) is a selective estrogen receptor the same class as tamoxifen. It mimics the effects of estrogen in some tissues...but not in others.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote